Roger van den Heuvel

Principal, Head of Life Sciences, Global Strategy Group

KPMG in the U.S.

As a partner at KPMG, Roger leads the Life Science sector within KPMG’s Global Strategy Group, which provides strategic advice through to execution support to current and future industry leaders across the globe. Roger has 20+ years of consulting experience and specializes in strategy formulation and (value-based) strategic transformations with a particular emphasis on disruptive technology/business models and ‘Future Proofing’. He’s been the (co-)author of several recent KPMG publications (e.g. Future proofing supply chains in Life Sciences, Pharma 2030, The future of Oncology and most recently on the future outlook of the Medical Device industry, Medical Devices 2030.


Areas of Expertise: Advisory, Deal Advisory, Deal strategy, Disruptive Technology, Healthcare, Life Sciences, Management Consulting, Pharmaceuticals, Strategy and Operations, Transformation


  • Advisory
  • Buy
  • Deal Advisory
  • Deal strategy
  • Healthcare
  • Life Sciences
  • Management Consulting
  • Pharmaceuticals
  • Strategy and Operations
  • Transformation
  • Harvard Business School, Advanced Management Program

  • Stanford University Graduate School of Business, Executive Leadership

  • INSEAD, Advanced Management Programme

  • Endhoven University of Technology, MSc. Industrial Engineering & Management Science

  • Vrije Universiteit Amsterdam, Philosophy